News

Published on 17 Apr 2024 on Zacks via Yahoo Finance

Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth


Article preview image

Wall Street expects a year-over-year increase in earnings on lower revenues when Biogen Inc. (BIIB) reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on April 24, 2024, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

NASDAQ.BIIB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

For Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured...

Zacks via Yahoo Finance 3 May 2024

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks via Yahoo Finance 1 May 2024

This midcap stock is up 11% after smashing earnings estimates this morning By Investing.com

This midcap stock is up 11% after smashing earnings estimates this morning

Investing.com 30 Apr 2024

At Biogen, CEO Viehbacher got less total pay than many executives last year - Boston Business...

When Christopher Viehbacher became CEO of Biogen Inc. in late 2022, he landed $30.5 million in to...

The Business Journals 29 Apr 2024

Decoding Biogen Inc (BIIB): A Strategic SWOT Insight

Biogen Inc's robust product portfolio and pipeline offer a competitive edge in the neurology and ...

GuruFocus.com via Yahoo Finance 26 Apr 2024

Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript

Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 Biogen Inc. misses on e...

Insider Monkey via Yahoo Finance 25 Apr 2024

Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake

Biogen BIIB reported first-quarter 2024 adjusted earnings per share (EPS) of $3.67, beating the Z...

Zacks via Yahoo Finance 24 Apr 2024

Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2024, Biogen Inc. (BIIB) reported revenue of $2.29 billion, down 7% o...

Zacks via Yahoo Finance 24 Apr 2024

Biogen stock gains on Q1 earnings beat (NASDAQ:BIIB)

Biogen (BIIB) reports improving uptake for its Alzheimer's therapy Leqembi with its Q1 2024 resul...

Seeking Alpha 24 Apr 2024

Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

gained 5.5% premarket on Wednesday after the company reported first-quarter profit that beat...

Market Watch 24 Apr 2024